| |
Newsletter 18/2010
26
October 2010
[gs]
Who Has $156b in
Sales? – GE Buying Clarient!
or: Is ITT the
Next Danaher?
If you do not
wish to receive this newsletter anymore, just reply to this mail
without any comment and you will be taken off the mailing list.
-----------------------------
Dear reader:
long-time readers of the [gs]
Newsletter know about my secret obsession with the large players, the
real large players, that are typically not considered as much as they
ought to be in “biotech circles”. I am talking
about Microsoft, Intel, google, Siemens, Philips and, of course
– like John Lennon once sang: »The greatest of them
all« – General
Electric Company, or for short: GE.
GE
means $ 156 billion in sales for ongoing operations in
2009! Now, last
Friday, GE Healthcare announced its intention to acquire Clarient, Inc.,
a cancer molecular diagnostics company!
How big is big? Putting things into the GE
perspective
Some remarks from an
ignorant, unknowing economist like me, to put things into perspective:
Take, for instance, Thermo Fisher, a
business group that calls itself "the world leader in serving
science" (Whatever and whoever that may be?! Anyway, we at [iito]
always loved that clever hook!). Let’s face it: they had about $ 10 billion sales in 2009.
Qiagen,
Germany’s largest biotech outfit, might be racing to become a
worldwide leader in molecular diagnostics, however, they will have to
do for the moment with 2009
net sales of $1b.
Now, take a look at this: The GE
Healthcare business unit of GE alone had sales of $ 16 billion
in 2009!
Below
you will find a fine collection
of interesting GE deals, selected from our gene-sensor
database within seconds, just to give you a slight impression of what
this big spider is doing in the life sciences / health care area.
Will ITT Corporation follow in the
footsteps of Danaher?
It was only when Danaher
(a $ 11 billion conglomerate) acquired
the mass spectrometry business of Life Technologies (formerly Applied
Biosystems) and MDS plus the Molecular Devices portfolio
of MDS in 2009, that we realised that Danaher already owned Leica Microsystems
since 2005. In addition we found that a Danaher subsidiary
has been also involved
in a genome sequencer project with George Church of
Harvard Medical School.
Take a look at these deals at www.gene-sensor.com:
[Please
note: details of the four deals listed below are accessible
only to [gs] subscribers!]
Life
Technologies–Danaher: mass spectrometer,
200909–201002 acquisition $450m in cash mass spectrometry
business from ABI
MDS–Danaher:
mass spectrometer, 200909– acquisition $650m in cash AB Sciex
mass spectrometry business + former Molecular Devices Corp
Leica–Danaher:
investment, 200507–200509 acquisition $550m Leica
Microsystems AG from LM Investments Sarl
Danaher–Harvard
Univ: Polonator G.007, –200810– collab existent
developm George Church HMS + production by Dover Systems
And last week “accidently” we became aware
of another $ 11
billion conglomerate moving into life sciences analytics: ITT
Corporation!
Actually, we received a press announcement for
an event by a fellow company from our home town, Bremen, Germany, that
included a reference to SI Analytics, and somebody at [iito] took a
closer look at that, realising that SI Analytics has been a brand of Nova Analytics,
which has been acquired
by ITT this March. After checking more recent ITT news we
saw that ITT in addition
just recently acquired OI Analytics (O.I. Corporation) in
September. You can read it here:
ITT
Corporation. (9/14/10). "Press Release: ITT to Enhance Global
Analytical Instrumentation Business with Acquisition of O.I.
Corporation". White Plains, NY & College Station,TX.
ITT
Corporation. (3/24/10). "Press Release: ITT Completes Acquisition of
Nova Analytics, a Global Leader in Analytical Instrumention". White
Plains, NY.
And so it goes all the time at [iito] Business Intelligence, we are
like a spider in the web, going from here to there, always connected by
a string or chain that “makes sense” and getting
the relevant information out of the news for our customers!
And the moral of this tale?
Life sciences and biotech have finally grown up!
I think the moral of this tale is quite simple. When several of the
world’s large conglomerates are moving aggressively into the life sciences and biotechnology
industries, this is a clear sign that these industries have reached a
critical scale, in other words: have
grown up! In addition they will be connected more and more
to the health care technology and analytical industries and together
these industries probably will grow for the foreseeable future and thus
will stay with us for a long time in the years to come.
We at [iito] have grown up also over the last 8 years and we hope you
will stay with us, too, for a long, long time!
Find below some relevant GE deals taken from [gs].
Thanks for reading, back in two weeks.
Marcus Lippold
------------------------------------
APPENDIX
Some interesting news from GE – provided
by [gs]
General
Electric Company. (10/22/10). "Press Release: GE Healthcare to Acquire
Cancer Diagnostic Company Clarient Inc. Addition of High-growth
Business Will Create Strong Technology-enabled Services Platform in
Molecular Diagnostics". Chalfont St. Giles
General
Electric Company. (8/17/10). "Press Release: GE Healthcare and Arineta
Ltd Announce Partnership to Tackle Cardiovascular Disease". Chalfont
St. Giles & Caesarea.
General
Electric Company. (8/2/10). "Press Release: GE, Intel to Form New
Healthcare Joint Venture. Company to Focus on Telehealth and
Independent Living in Effort to Tackle Increasing Global Burden of
Chronic Disease and Age-related Conditions".
General
Electric Company. (5/18/10). "Press Release: GE Healthcare Completes
Acquisition of Sanesco, a Leading Healthcare Advisory Services Company
in France". Paris.
General
Electric Company. (5/13/10). "Press Release: GE Healthcare Forms
Strategic Alliance with Cardiovascular Genomic Diagnostic Company,
CardioDx. Companies to Advance Development of High-value Integrated
Diagnostics for Cardiovascular Disease".
General
Electric Company. (4/27/10). "Press Release: GE Healthcare and Nycomed
to Form Joint Venture to Sell, Market and Distribute Medical Diagnostic
Contrast Agents in Russia and CIS". Moscow.
General
Electric Company. (12/4/09). "Press Release: GE Healthcare Acquires
Living Independently Group Inc. Acquisition Expands GE
Healthcare’s Home Health Business, Will Accelerate
Development of Technologies for Care of Seniors".
General
Electric. (10/21/09). "Press Release: GE Launches $250 Million
Healthymagination Fund. New Equity Investment Fund to Invest in High
Potantial Healthcare Technology Companies – Supports
GE’s Global Healthymagination Initiative, Focusing on Cost,
TomTec
Imaging Systems GmbH. (8/25/09). "Press Release: GE Healthcare and
Tomtec Announce Strategic Cooperation in Cardiology IT". Munich.
Fujifilm
Corporation. (5/28/09). "Press Release: Fujifilm and GE Healthcare Form
Strategic Alliance in Life Sciences. Global Alliance in Biomolecular
Imaging".
Varian,
Inc.. (5/12/09). "Press Release: GE Healthcare and Varian, Inc.
Announce Pre-clinical Magnetic Resonance Imaging (MRI) System". Palo
Alto, CA.
[The list continues and continues! Just give gene-sensor.com a try!]
-----------------------------------------------------------------------------------
©2010 by
[iito] Business Intelligence
NOTES & DISCLAIMER
Some links are available to subscribers
only. As this
newsletter is a free service, available to anybody without a
contractual
agreement, the writer disclaims any liabilities and explicitly advises
you, not to use this information for your own business
decisions.
I hope you enjoy reading these lines as much as I have enjoyed writing
them!
Thank you.
Marcus Lippold
Dipl.-Oek. (Economist)
[iito] Business Intelligence
Parkallee 24
28209 Bremen
Germany
Phone +49(0)-421-9889 173
E-mail mlippold@iito.de
Web www.gene-sensor.com
This
communication is confidential. If you are not the intended recipient,
you should not copy or disclose the message to anyone, but should
kindly
notify the sender and delete the message.
|
|
